Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MEDICAL INNOVATION HOLDINGS, INC.Financial_Report.xls
10-K - MEDICAL INNOVATION HOLDINGS, INC.mihi10k.txt
EX-32 - MEDICAL INNOVATION HOLDINGS, INC.rmex32.txt
EX-31 - MEDICAL INNOVATION HOLDINGS, INC.dmex31.txt
EX-31 - MEDICAL INNOVATION HOLDINGS, INC.rmex31.txt

                                  Exhibit 32.1

                     CERTIFICATION OF DISCLOSURE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Medina International  Holdings,  Inc.
(the "Company") on Form 10-K for the year ended April 30, 2012 as filed with the
Securities  and Exchange  Commission on the date hereof (the "Report") I, Daniel
F. Medina,  President and Principal  Executive Officer of the Company,  certify,
pursuant  to 18 USC  Section  1350,  as adopted  pursuant  to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Dated: August 13, 2012

/s/Daniel F. Medina

 -------------------------------------------------------------------------------
Daniel F. Medina, (President & Principal Executive Officer)


This  certification  accompanies  the  Report  pursuant  to  Section  906 of the
Sarbanes-Oxley  Act of 2002 and shall not,  except to the extent required by the
Sarbanes-Oxley  Act of 2002,  be deemed  filed by the  Company  for  purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.